Get the Stockscreener App
0.2978
8.29%
0.0228
Leap Therapeutics Inc stock is traded at $0.2978, with a volume of 1.02M.
It is up +8.29% in the last 24 hours and down -15.16% over the past month.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
See More
Previous Close:
$0.275
Open:
$0.271
24h Volume:
1.02M
Relative Volume:
0.59
Market Cap:
$12.34M
Revenue:
$1.50M
Net Income/Loss:
$-64.59M
P/E Ratio:
-0.1783
EPS:
-1.67
Net Cash Flow:
$-55.17M
1W Performance:
+11.08%
1M Performance:
-15.16%
6M Performance:
-37.98%
1Y Performance:
-89.13%
1-Day Range:
$0.271
$0.30
1-Week Range:
$0.26
$0.3093
52-Week Range:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Name
Leap Therapeutics Inc
Sector
Industry
Phone
617 252 4343
Address
47 THORNDIKE STREET, CAMBRIDGE, MA
Compare LPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.2978 | 11.95M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-29-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
| Feb-11-20 | Initiated | Robert W. Baird | Outperform |
| Nov-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-13-19 | Resumed | Raymond James | Outperform |
| Mar-07-17 | Initiated | Ladenburg Thalmann | Buy |
View All
Leap Therapeutics Inc Stock (LPTX) Latest News
What recovery options are there for Leap Therapeutics Inc.July 2025 Price Swings & High Conviction Trade Alerts - Newser
Relative strength of Leap Therapeutics Inc. in sector analysisQuarterly Profit Summary & Smart Allocation Stock Reports - Newser
How to escape a deep drawdown in Leap Therapeutics Inc.Weekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Does Leap Therapeutics Inc. show high probability of reboundJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Is it time to cut losses on Leap Therapeutics Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Does Leap Therapeutics Inc. fit your quant trading modelJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - Newser
Has Leap Therapeutics Inc. found a price floor2025 Top Gainers & High Accuracy Swing Trade Signals - Newser
What technical models suggest about Leap Therapeutics Inc.’s comebackWeekly Trade Report & Low Risk Investment Opportunities - Newser
What indicators show strength in Leap Therapeutics Inc.Trend Reversal & Daily Technical Forecast Reports - Newser
Published on: 2025-08-19 15:50:16 - Newser
News impact scoring models applied to Leap Therapeutics Inc.July 2025 Recap & Safe Capital Investment Plans - Newser
Pattern recognition hints at Leap Therapeutics Inc. upside2025 Price Action Summary & Weekly Market Pulse Alerts - Newser
What earnings revisions data tells us about Leap Therapeutics Inc.July 2025 Recap & Entry Point Confirmation Signals - Newser
Published on: 2025-08-19 04:14:39 - Newser
Chart overlay techniques for tracking Leap Therapeutics Inc.2025 Trading Recap & AI Forecast for Swing Trade Picks - Newser
How to recover losses in Leap Therapeutics Inc. stockJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
Leap Therapeutics Inc. Shows Early Signs of Technical Strength2025 Buyback Activity & Real-Time Volume Trigger Notifications - kangso.co.kr
LPTX Stock: A Comprehensive Analysis and Forecast - investchronicle.com
Leap Therapeutics Posts Q2 2025 Loss Amid High R&D Spend; Earnings Momentum Points to Long-Term Potential - AInvest
Applying Elliott Wave Theory to Leap Therapeutics Inc.Market Growth Report & Safe Swing Trade Setups - Newser
Leap Therapeutics Inc. stock retracement – recovery analysisWeekly Market Outlook & Weekly Stock Performance Updates - Newser
Does Leap Therapeutics Inc. stock pay reliable dividendsJuly 2025 Breakouts & Long-Term Safe Investment Ideas - Newser
Is Leap Therapeutics Inc. stock reversal real or fakeLayoff News & Growth Focused Stock Reports - Newser
Is Leap Therapeutics Inc. stock entering bullish territoryJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
Leap Therapeutics Posts Earnings Miss Amid Rising R&D Costs, But Historical Backtests Suggest Strong Post-Beat Momentum - AInvest
Is Leap Therapeutics Inc. exposed to political risk2025 Investor Takeaways & Free Verified High Yield Trade Plans - 선데이타임즈
Using data filters to optimize entry into Leap Therapeutics Inc.Gap Down & Verified Momentum Stock Watchlist - Newser
What data driven models say about Leap Therapeutics Inc.’s future2025 Geopolitical Influence & Proven Capital Preservation Methods - Newser
Top chart patterns to watch in Leap Therapeutics Inc.July 2025 Setups & Safe Capital Allocation Plans - Newser
When is the best time to exit Leap Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Why Leap Therapeutics Inc. stock attracts strong analyst attentionQuarterly Portfolio Report & AI Enhanced Execution Alerts - Newser
Sector ETF performance correlation with Leap Therapeutics Inc.Quarterly Trade Review & Safe Entry Point Identification - Newser
How to monitor Leap Therapeutics Inc. with trend dashboards2025 Dividend Review & Free Real-Time Market Sentiment Alerts - Newser
Analyzing Leap Therapeutics Inc. with multi timeframe chartsOptions Play & Scalable Portfolio Growth Ideas - Newser
Leap Therapeutics (LPTX) Surges 11.95% on Intraday Rally – What’s Fueling the Biotech Breakout? - AInvest
Leap Therapeutics shares rise 2.46% premarket after reporting earnings results. - AInvest
Leap Therapeutics Inc Stock (LPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):